241 related articles for article (PubMed ID: 34242487)
21. Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer.
Ernani V; Du L; Ross HJ; Yi JE; Wampfler JA; Schild SE; Xie H; Swanson KL; Tazelaar HD; Yang P
Thorac Cancer; 2022 Apr; 13(7):925-933. PubMed ID: 35194958
[TBL] [Abstract][Full Text] [Related]
22. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
24. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
25. Long lasting trigeminal neuropathy, limbic encephalitis and abdominal ganglionitis without primary cancer: An atypical case of Hu-antibody syndrome.
De Schamphelaere E; Sieben A; Heyndrickx S; Lammens M; Geboes K; De Bleecker JL
Clin Neurol Neurosurg; 2020 Jul; 194():105849. PubMed ID: 32388246
[TBL] [Abstract][Full Text] [Related]
26. Anti-Hu paraneoplastic syndrome presenting with brainstem-cerebellar symptoms and Lambert-Eaton myasthenic syndrome.
Nagashima T; Mizutani Y; Kawahara H; Maguchi S; Terayama Y; Shinohara T; Orba Y; Chuma T; Mano Y; Itoh T; Sawa H; Sakai K; Motomura M; Nagashima K
Neuropathology; 2003 Sep; 23(3):230-8. PubMed ID: 14570293
[TBL] [Abstract][Full Text] [Related]
27. Integrated treatment for autonomic paraneoplastic syndrome improves performance status in a patient with small lung cell carcinoma: a case report.
Ueno T; Hasegawa Y; Hagiwara R; Kon T; Nunomura JI; Tomiyama M
BMC Neurol; 2018 Nov; 18(1):189. PubMed ID: 30414621
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of paraneoplastic neurological syndromes: a population-based study.
Vogrig A; Gigli GL; Segatti S; Corazza E; Marini A; Bernardini A; Valent F; Fabris M; Curcio F; Brigo F; Iacono D; Passadore P; Rana M; Honnorat J; Valente M
J Neurol; 2020 Jan; 267(1):26-35. PubMed ID: 31552550
[TBL] [Abstract][Full Text] [Related]
29. Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.
Iams WT; Shiuan E; Meador CB; Roth M; Bordeaux J; Vaupel C; Boyd KL; Summitt IB; Wang LL; Schneider JT; Warner JL; Zhao Z; Lovly CM
J Thorac Oncol; 2019 Nov; 14(11):1970-1981. PubMed ID: 31201935
[TBL] [Abstract][Full Text] [Related]
30. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
31. Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China.
Miao S; Liao S; Li H; Niu B; Hu H; Qian Y; Guo H; Cao B
Int J Neurosci; 2018 Sep; 128(9):821-827. PubMed ID: 29355452
[TBL] [Abstract][Full Text] [Related]
32. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
33. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
Raibagkar P; Ho D; Gunturu KS; Srinivasan J
J Neuroimmunol; 2020 Apr; 341():577184. PubMed ID: 32058173
[TBL] [Abstract][Full Text] [Related]
34. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
Zaborowski MP; Stefens-Stawna P; Osztynowicz K; Piorunek T; Batura-Gabryel H; Dyzmann-Sroka A; Kozubski W; Nowak-Markwitz E; Michalak S
Cancer Immunol Immunother; 2021 May; 70(5):1277-1289. PubMed ID: 33136178
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndrome with positive anti-Hu and anti-Yo antibodies: A case report.
Li ZC; Cai HB; Fan ZZ; Zhai XB; Ge ZM
World J Clin Cases; 2022 May; 10(13):4190-4195. PubMed ID: 35665124
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
Bataller L; Graus F; Saiz A; Vilchez JJ;
Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
[TBL] [Abstract][Full Text] [Related]
39. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
Titulaer MJ; Wirtz PW; Willems LN; van Kralingen KW; Smitt PA; Verschuuren JJ
J Clin Oncol; 2008 Sep; 26(26):4276-81. PubMed ID: 18779614
[TBL] [Abstract][Full Text] [Related]
40. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
